Sarepta Therapeutics, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Sarepta Therapeutics, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Sarepta Therapeutics, Inc. stocks after a simple registration process. </div>

Q: How to buy Sarepta Therapeutics, Inc. shares in India?

<div> To buy Sarepta Therapeutics, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Sarepta Therapeutics, Inc. and you are done!</div> </div>

Q: What is the share price of Sarepta Therapeutics, Inc.?

<div>The share price of Sarepta Therapeutics, Inc. is USD 120.34 as on 18 Dec.</div>

Q: What is the Market Capitalization of Sarepta Therapeutics, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Sarepta Therapeutics, Inc. is USD 11.49B as on 18 Dec.</div>

Q: What is the PE ratio of Sarepta Therapeutics, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Sarepta Therapeutics, Inc. is 82.20 as on 18 Dec. </div>

Q: Is Sarepta Therapeutics, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Sarepta Therapeutics, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Sarepta Therapeutics, Inc. operate?

<div> Sarepta Therapeutics, Inc. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$120.34

-5.46

(18 Dec)

Loading Chart

Previous close

$120.34

Open

$120.34

Today’s high

$126.04

Today’s low

$119.84

52W low

$89.92

52W high

$173.25

28.03%

-1.01%

82.20

EPS (TTM)

1.53

Shares O/S

95.52M

Market cap

11.49B

Insights

SRPT price is below its 200 day moving average

SRPT PE is in the highest 10% across all stocks. The market is valuing it as a growth stock on an earnings basis.

In beta. Send feedback here.

Compare with other stock

About Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders.

It has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS. Its pipeline includes approximately 40 programs at various stages of discovery, pre-clinical and clinical development. .

FAQs

Can I buy Sarepta Therapeutics, Inc. shares in India?

How to buy Sarepta Therapeutics, Inc. shares in India?

What is the share price of Sarepta Therapeutics, Inc.?

What is the Market Capitalization of Sarepta Therapeutics, Inc.?

What is the PE ratio of Sarepta Therapeutics, Inc.?

Is Sarepta Therapeutics, Inc. a good stock to buy?

In which sector / industry does Sarepta Therapeutics, Inc. operate?